PH12013500052B1 - Immunogenic anti-inflammatory compositions - Google Patents
Immunogenic anti-inflammatory compositionsInfo
- Publication number
- PH12013500052B1 PH12013500052B1 PH1/2013/500052A PH12013500052A PH12013500052B1 PH 12013500052 B1 PH12013500052 B1 PH 12013500052B1 PH 12013500052 A PH12013500052 A PH 12013500052A PH 12013500052 B1 PH12013500052 B1 PH 12013500052B1
- Authority
- PH
- Philippines
- Prior art keywords
- tissue
- inflammatory
- specific organ
- composition
- specific
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 230000003110 anti-inflammatory effect Effects 0.000 title abstract 3
- 230000002163 immunogen Effects 0.000 title 1
- 210000000056 organ Anatomy 0.000 abstract 4
- 230000000890 antigenic effect Effects 0.000 abstract 3
- 230000001717 pathogenic effect Effects 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 244000052769 pathogen Species 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000031990 negative regulation of inflammatory response Effects 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The invention provides methods of formulating an anti-inflammatory composition for treating inflammatory conditions in a specific organ or tissue. The method involves selecting at least one pathogen that is pathogenic in the specific organ or tissue; producing an antigenic composition comprising antigenic determinants that together are specific for the pathogen; and formulating the antigenic composition for administration as an anti-inflammatory composition capable of eliciting an anti-inflammatory response in the specific organ or tissue, wherein the condition characterized by inflammation is not a cancer. In embodiments of the invention, a cancer is situated in the specific organ or tissue.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201013019208A | 2010-02-01 | 2010-02-01 | |
| US50083610P | 2010-06-24 | 2010-06-24 | |
| US12/843,296 US8501198B2 (en) | 2004-06-07 | 2010-07-26 | Tissue targeted antigenic activation of the immune response to treat cancers |
| US41137110P | 2010-11-08 | 2010-11-08 | |
| PCT/CA2011/000851 WO2012012874A1 (en) | 2010-07-26 | 2011-07-26 | Immunogenic anti-inflammatory compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PH12013500052A1 PH12013500052A1 (en) | 2012-02-02 |
| PH12013500052B1 true PH12013500052B1 (en) | 2019-06-28 |
Family
ID=94381975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH1/2013/500052A PH12013500052B1 (en) | 2010-02-01 | 2011-07-26 | Immunogenic anti-inflammatory compositions |
Country Status (1)
| Country | Link |
|---|---|
| PH (1) | PH12013500052B1 (en) |
-
2011
- 2011-07-26 PH PH1/2013/500052A patent/PH12013500052B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH12013500052A1 (en) | 2012-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY188328A (en) | Immunogenic anti-inflammatory compositions | |
| CY1123208T1 (en) | CYCLIC BORONIC ACID ESTERS, METHOD OF PREPARATION AND THERAPEUTIC USES THEREOF | |
| AR118199A2 (en) | IMMUNOGENIC COMPOSITIONS OF NON-LIPID NON-PIRUVILATED VARIANTS OF ORF2086 ANTIGENS FROM NEISSERIA MENINGITIDIS, POLIPEPTIDES, NUCLEOTIDE SEQUENCES AND PLASMIDS | |
| MX2013004817A (en) | INFLAMMATORY DISEASE. | |
| IN2012DN01898A (en) | ||
| MX364229B (en) | COMPOSITIONS and METHODS FOR TREATING CARDIOVASCULAR DISEASES. | |
| PH12014501836A1 (en) | Novel adjuvant compositions | |
| WO2011130164A3 (en) | Unconjugated anti-tfr antibodies and compositions thereof for the treatment of cancer | |
| MX2012000434A (en) | Method of wound healing and scar modulation. | |
| TN2011000374A1 (en) | Antibody molecules having specificity for human ox40 | |
| PH12014500946A1 (en) | Antibody molecules having specificity for human ox40 | |
| GEP20166457B (en) | Low-oil pharmaceutical emulsion compositions comprising progestogen | |
| UA109868C2 (en) | N -alkyltriazole compounds asr | |
| MY164842A (en) | Isoxazolidine derivatives | |
| CY1123056T1 (en) | NEW FORM OF ADMINISTRATION OF RACECADOTRIL | |
| DK2252322T3 (en) | vaccine Compositions | |
| TN2013000313A1 (en) | Isoxazolidine derivatives | |
| UA110332C2 (en) | Use of 2,3-dihydroxypropyldodecanoate for treatment of seborrhea | |
| MY174818A (en) | Immunogenic compostion comprising mycoplasma antigens | |
| MX2012007283A (en) | Vaccine compositions. | |
| WO2011044587A3 (en) | Cytoprotective or therapeutic plant composition | |
| PH12013500052B1 (en) | Immunogenic anti-inflammatory compositions | |
| NZ607792A (en) | Improved vaccine compositions | |
| CO6680627A2 (en) | Immunogenic anti-inflammatory compositions | |
| CY1119704T1 (en) | Trisaccharide derivatives, and their use as immunosuppressants |